From Evidence-based Medicine to Marketing-based Medicine: Evidence from Internal Industry Documents

Glenn Spielmans, Peter Parry

    Research output: Contribution to journalArticlepeer-review

    72 Citations (Scopus)

    Abstract

    While much excitement has been generated surrounding evidence-based medicine, internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.

    Original languageEnglish
    Pages (from-to)13-29
    Number of pages17
    JournalJournal of Bioethical Inquiry
    Volume7
    Issue number1
    DOIs
    Publication statusPublished - Mar 2010

    Keywords

    • Evidence-based medicine
    • Marketing
    • Marketing-based medicine
    • Olanzapine
    • Pharmaceutical industry
    • Quetiapine

    Fingerprint Dive into the research topics of 'From Evidence-based Medicine to Marketing-based Medicine: Evidence from Internal Industry Documents'. Together they form a unique fingerprint.

    Cite this